Fundraising Fox

Tigatx

2 known investors

Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach. The company focuses on first-in-class immunotherapy for cancer patients.

Investors · 2

Competitors · 5

by search overlap

Companies competing with Tigatx for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Tigatx do?
Tigatx develops engineered IgA antibodies designed to engage neutrophils as a cancer treatment approach. The company focuses on first-in-class immunotherapy for cancer patients.
Who are Tigatx's investors?
Tigatx's investors include Civilization Ventures Management, Llc, BioGeneration Ventures.